These benefits, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 guidance the strategy of targeting ACKR3 as a novel method to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-linked Conditions. Assists to scale back chronic https://georgesy514ggc5.newsbloger.com/profile